229 related articles for article (PubMed ID: 37499118)
21. Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways.
Wang L; Moreira EA; Kempf G; Miyake Y; Oliveira Esteves BI; Fahmi A; Schaefer JV; Dreier B; Yamauchi Y; Alves MP; Plückthun A; Matthias P
Cell Rep; 2022 Apr; 39(4):110736. PubMed ID: 35476995
[TBL] [Abstract][Full Text] [Related]
22. Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6.
Porter NJ; Wagner FF; Christianson DW
Biochemistry; 2018 Jul; 57(26):3916-3924. PubMed ID: 29775292
[TBL] [Abstract][Full Text] [Related]
23. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
[TBL] [Abstract][Full Text] [Related]
25. Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.
Yan J
DNA Cell Biol; 2014 Sep; 33(9):567-80. PubMed ID: 24932665
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a fluorescent probe with HDAC6 selective inhibition.
Zhang Y; Yan J; Yao TP
Eur J Med Chem; 2017 Dec; 141():596-602. PubMed ID: 29102179
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors.
Ashraf QF; Quilates EJ; Olaoye OO; de Araujo ED; Gunning PT
Methods Mol Biol; 2023; 2589():481-492. PubMed ID: 36255644
[TBL] [Abstract][Full Text] [Related]
28. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
29. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
Ruzic D; Djokovic N; Nikolic K
Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
[TBL] [Abstract][Full Text] [Related]
30. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
[TBL] [Abstract][Full Text] [Related]
31. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
[TBL] [Abstract][Full Text] [Related]
32. Curriculum vitae of HDAC6 in solid tumors.
Zheng YC; Kang HQ; Wang B; Zhu YZ; Mamun MAA; Zhao LF; Nie HQ; Liu Y; Zhao LJ; Zhang XN; Gao MM; Jiang DD; Liu HM; Gao Y
Int J Biol Macromol; 2023 Mar; 230():123219. PubMed ID: 36642357
[TBL] [Abstract][Full Text] [Related]
33. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
[TBL] [Abstract][Full Text] [Related]
34. A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
New M; Olzscha H; Liu G; Khan O; Stimson L; McGouran J; Kerr D; Coutts A; Kessler B; Middleton M; La Thangue NB
Cell Death Differ; 2013 Oct; 20(10):1306-16. PubMed ID: 23703321
[TBL] [Abstract][Full Text] [Related]
35. Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).
He X; Li Z; Zhuo XT; Hui Z; Xie T; Ye XY
Recent Pat Anticancer Drug Discov; 2020; 15(1):32-48. PubMed ID: 32065106
[TBL] [Abstract][Full Text] [Related]
36. Vitamin K
Dawood M; Hegazy MF; Elbadawi M; Fleischer E; Klinger A; Bringmann G; Kuntner C; Shan L; Efferth T
Biochem Pharmacol; 2020 Oct; 180():114176. PubMed ID: 32721508
[TBL] [Abstract][Full Text] [Related]
37. The Role of HDAC6 in Autophagy and NLRP3 Inflammasome.
Chang P; Li H; Hu H; Li Y; Wang T
Front Immunol; 2021; 12():763831. PubMed ID: 34777380
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group.
Linciano P; Pinzi L; Belluti S; Chianese U; Benedetti R; Moi D; Altucci L; Franchini S; Imbriano C; Sorbi C; Rastelli G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2080-2086. PubMed ID: 34583596
[TBL] [Abstract][Full Text] [Related]
39. The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
Balmik AA; Sonawane SK; Chinnathambi S
Cell Commun Signal; 2021 May; 19(1):49. PubMed ID: 33933071
[TBL] [Abstract][Full Text] [Related]
40. Ciliopathies: Does HDAC6 Represent a New Therapeutic Target?
Yu F; Ran J; Zhou J
Trends Pharmacol Sci; 2016 Feb; 37(2):114-119. PubMed ID: 26651415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
